DISEASE INDICATIONS: Thyroid Eye Disease

MANUFACTURER: Horizon Therapeutics plc

USAGE: Intravenous

MEDICINE APPROVED BY:

Food and Drug Administration (FDA)

Tepezza (teprotumumab-trbw) is used to treat Thyroid Eye Disease (TED), otherwise known as Grave’s Eye Disease, when the condition is in its active phase.